Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study

Abstract

Results from this study suggest that the EMSC implants were well tolerated and efficacious in dogs with KCS responsive to topical CsA as well as dogs with poor response to topical therapy. Further study is needed to determine the duration of efficacy and optimal dose of CsA.